🇺🇸 FDA
Pipeline program

GLUCOPHAGE 500 mg tabletki powlekane, Placebo

2020/ABM/01/00100

Phase 3 small_molecule active

Quick answer

GLUCOPHAGE 500 mg tabletki powlekane, Placebo for papillary thyroid carcinoma is a Phase 3 program (small_molecule) at Bial Portela & Companhia S.A. with 1 ClinicalTrials.gov record(s).

Program details

Company
Bial Portela & Companhia S.A.
Indication
papillary thyroid carcinoma
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials